Ginkgo Bioworks Holdings (DNA) EBIAT (2020 - 2025)
Historic EBIAT for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$80.8 million.
- Ginkgo Bioworks Holdings' EBIAT fell 4317.5% to -$80.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.5 million, marking a year-over-year increase of 4785.75%. This contributed to the annual value of -$547.0 million for FY2024, which is 3873.36% up from last year.
- Ginkgo Bioworks Holdings' EBIAT amounted to -$80.8 million in Q3 2025, which was down 4317.5% from -$60.3 million recorded in Q2 2025.
- Over the past 5 years, Ginkgo Bioworks Holdings' EBIAT peaked at -$54.5 million during Q2 2021, and registered a low of -$1.6 billion during Q4 2021.
- Its 5-year average for EBIAT is -$295.5 million, with a median of -$173.1 million in 2022.
- Per our database at Business Quant, Ginkgo Bioworks Holdings' EBIAT crashed by 335911.55% in 2021 and then skyrocketed by 8921.63% in 2022.
- Ginkgo Bioworks Holdings' EBIAT (Quarter) stood at -$1.6 billion in 2021, then skyrocketed by 89.22% to -$173.1 million in 2022, then fell by 22.31% to -$211.7 million in 2023, then soared by 49.2% to -$107.5 million in 2024, then increased by 24.9% to -$80.8 million in 2025.
- Its EBIAT stands at -$80.8 million for Q3 2025, versus -$60.3 million for Q2 2025 and -$91.0 million for Q1 2025.